Skip to main content

As Houston Life Sciences Sector Heats Up, Developers Delivering On Needed Space

Published Jun 07, 2022 by A.J. Mistretta

levit green.jpg

A rendering of Levit Green

Texas A&M TMC.jpg

A rendering of Texas A&M's Innovation Plaza

A life sciences real estate building boom is sweeping the nation, driven by sharp increases in health-related VC funding, promising new therapies from pharmaceutical companies and a shortage of available space, particularly in emerging markets. 

Investment in U.S. life sciences real estate increased 62% in 2021, according to a report from commercial real estate firm CBRE. Investment in the sector has grown by 111% since 2018 and another 10% increase is forecast for 2022, with much of that new investment going to ground-up development. 

Industry watchers are pointing to Houston as one rapidly evolving market where proximity to the world’s largest medical center and a diverse and educated population are fueling interest from established life sciences and biotech companies aiming to grow, just as new startups hatched out of local research institutions look to scale. 

Life sciences/health care led among the local sectors in venture capital funding for four of the last five years and accounted for 26% of all VC funding in the market in 2021. Promising startups and new technology are adding to an already robust market with more than 1,700 life sciences firms, hospitals and research institutions currently operating in the region. Big players such as Abbott, Bayer, Merck and Novartis already have a strong local presence. 

Commercial space for life sciences companies, including lab space, offices and more, has been scarce, but a series of projects near Houston’s core are underway to satisfy growing demand. At the same time, a mounting cohort of companies are looking outside the urban center for affordable space in promising suburban districts like The Woodlands, Pearland, Sugar Land and League City.  

Here’s an updated look at several major projects: 

TMC3

Texas Medical Center is slated to deliver the first phase of its ambitious 37-acre TMC3 collaborative research campus in 2023. The 250,000-square-foot Collaborative Building will include a large-scale research lab, office space, 7,000-square-foot atrium and more. A hotel and conference center, residential and retail space, as well as six additional industry and research buildings are included in the project’s master plan. TMC is working in collaboration with other founding institutions to create the campus centered around a series of parks in the shape of a double helix. The partners include the University of Texas MD Anderson Cancer Center, Texas A&M University Health Sciences Center and the University of Texas Health Science Center at Houston. Learn more

Levit Green 

Hines is slated to complete the first phase of its 53-acre Levit Green life sciences campus this year. The initial five-story building will create 294,000 square feet of space overlooking a plaza and a manmade lake. In time, Hines and its project partners 2ML Real Estate and Harrison Street hope to create roughly 4 million square feet of development on the site located between Hermann Park and Texas 288. Learn more

Texas A&M Innovation Plaza 

Texas A&M University and its development partners Medistar Corp. and Healthcare Trust of America are well underway on Texas A&M Innovation Plaza, a new five-acre campus within the Texas Medical Center and adjacent to the TMC Transition Station. The project is centered around a common green space will include three towers: EnMed Tower, an 18-story, 280,000-square-foot academic building anchored by the university’s Engineering-Medicine (EnMed) program; Life Tower, a 19-story, student housing building; and the 30-story Horizon Tower, which will include 17 floors of life sciences, dry and wet labs, restaurants, retail, and medical office space atop a 2,600-space parking garage. Horizon Tower is slated for completion in Q1 2024. Learn more
 

Learn more about the life sciences industry in Houston.

Related News

Life Sciences

Houston Primed for Life Sciences Boom

11/17/22
HOUSTON (November 17, 2022) – The Greater Houston Partnership commissioned Newmark Consulting Group to conduct a study, sponsored by San Jacinto College, Lone Star College, Houston Community College, and McCord Development, focused on assessing the Houston region’s existing resources and value proposition in the life sciences industry.  Findings identified Houston’s industry-leading expertise in cell and gene therapy, biologic drug development, and molecular diagnostics; a continuous flow of new talent from regional universities; an emerging and robust commitment by community colleges to support two-year degree pathways to meet industry demands and the ability for life science companies to grow and thrive in the market. The study also identified strategic next steps for the Houston region to capitalize on these advantages.  “The Newmark study confirms what we knew to be true about the potential for life sciences growth in Houston,” said Susan Davenport, Chief Economic Development Officer of the Greater Houston Partnership. “The study will help us coalesce our regional partners around a cohesive strategy to grow and expand the industry in Houston.” Home to nearly 700 life science companies, Houston consistently ranks as a top-15 market for life sciences employment nationwide and first in Texas. Houston benefits from the densest patient population in the world, allowing for transformational clinical applications. With Houston’s robust and diverse workforce, an extensive university ecosystem and education infrastructure, along with world class research institutions, Houston is primed to capture extensive subsector gains.  Houston ranks second in the nation in clinical trial volume, with more than 4,600 currently active clinical trials, representing 15% of all active U.S. trials. Houston-area institutions received $864.1 million in National Institutes of Health (NIH) grant funding, up 16.3% from 2020. In the last five years, the region received nearly $3.9 billion in NIH funding, an average of $740.7 million per year. Supported by the world-class institutions that comprise the Texas Medical Center and Houston’s sizeable patient population, expansive opportunities exist for commercial synergies with leading healthcare providers in the region.  As a hub for translational and clinical research and pharmaceutical and medical device manufacturing, Houston is home to more than 26,000 non-healthcare life science employees. Houston’s robust life sciences workforce ranks 12th in the nation, on par with numbers reported for Research Triangle Park. Additionally, Houston compares favorably given its central U.S. location, ample space available and under construction throughout the region, a business friendly environment including accelerated development timelines, and the logistics benefits of  two international airports and the Port of Houston.  The study finds Houston has the elements necessary to attract key subsectors of the life sciences industry, particularly in cell and gene therapy manufacturing; molecular diagnostics; and biologics drug development and manufacturing. The study also identifies specific strategies to optimize the region’s “go-to-market” plan to attract more companies in this highly competitive industry.   These recommendations include accelerating workforce development programs to produce new graduates in key life sciences occupations, refining Houston’s marketing messages to highlight the region’s existing life sciences” assets and activities within life science R&D and manufacturing.  Finally, the study identified the need to develop a shared regional strategy to attract and retain leading life sciences companies.  The Partnership has assembled task forces to implement the recommendations, which will be led by the organization’s Life Sciences Committee, chaired by Ferran Prat, Senior Vice President of Industry Relations and Research at MD Anderson Cancer Center. ### Greater Houston Partnership The Greater Houston Partnership works to make Houston one of the best places to live, work and build a business. As the economic development organization for the region, the Partnership champions growth across 12 counties by bringing together business and civic-minded leaders who are dedicated to the area’s long-term success. Representing 950 member organizations and approximately one-fifth of the region’s workforce, the Partnership is the place companies come together to make an impact. Learn more at Houston.org. Contact:  A.J. Mistretta amistretta@houston.org  504-450-3516
Read More
Industry Event

TMC Announces New 500-Acre Biomanufacturing Campus, Additional Expansion Plans

9/22/22
The Texas Medical Center plans to expand by building a new biomanufacturing facility, TMC BioPort, that aims to further advance Houston’s life sciences ecosystem. Bill McKeon, President and CEO of TMC, shared the announcement during the Partnership’s annual State of the Texas Medical Center event this week.  “TMC BioPort will be the home of our biomanufacturing. This will be a new 500-acre campus and we are still in the due diligence phase. We believe this alone will add another 100,000 jobs,” McKeon said.  In addition to serving as the primary biomanufacturing and medical supplies distribution engine, BioPort will offer an on-site upskill training center. McKeon said the COVID-19 pandemic revealed the importance of having manufacturing facilities like the BioPort in the region. The new campus is expected to create over 100,000 new jobs as the region works to meet the increased demand for biomanufacturing capacities. McKeon added the new campus will double the size of TMC in roughly five years.  McKeon also announced that TMC Innovation Factory Labs will open in the first quarter of 2023 at the TMC Innovation campus, which opened in 2015 in the former Nabisco Cookie Factory.  TMC Helix Park, formerly known as TMC3, will serve as the anchor of the multiple districts. Phase one of the 37-acre life science campus is slated for completion in 2023. McKeon said Helix Park will encourage collaboration among industry, academia and entrepreneurs through more than six million square feet of developed space as well as nearly 19 acres of green space. The TMC3 Collaborative Building, the first multi-institutional research facility in TMC’s history, is expected to finish next year. The project is expected to  add 27,000 jobs to the area.  TMC and its 61 institutions are consistently attracting recognition nationwide as some of the top hospitals and universities, contributing to Houston’s rising position at the forefront of advancing life sciences. Houston ranks as No. 2 in the U.S. by CBRE for the top emerging life science clusters.   “I know the Texas Medical Center will continue to thrive not only as an economic powerhouse for the region but will spearhead accelerating Houston as a global leader in life sciences and health care,” said the Partnership’s President and CEO Bob Harvey.   Read more about Houston’s life sciences industry.
Read More

Related Events